The Data Behind Successful Gene Therapy Launches: Best Practices for High-Engagement Assets
Wed, Sep 16
|
04:05 PM - 04:30 PM
125
Session details:
- Provide an evidence-based review of recent gene therapy launches - this session combines commercial performance data, analyst perspectives, and first-hand insights from launch leaders.
- Benchmark what sets high-performing launches apart, across the full commercialization lifecycle—from pre-approval planning through real-world adoption.
- Identify the commercial capabilities that most strongly correlate with launch success, including access strategy, patient identification, ecosystem mapping, and site engagement.
- Surface the operational barriers that consistently limit uptake and the best practices leading innovators use to overcome them.
- Translate data-backed lessons from gene therapy launches into sharper commercialization strategies for any high-engagement or specialty asset
